We are building the bridge between complex molecular data and everyday clinical decisions
Built on Snowflake Cortex AI, the agent enables representatives to generate comprehensive pre-call plans through a single conversational interface
Approval for generic version of Xeljanz enables immediate launch and strengthens Aurobindo’s U.S. portfolio with its 586th ANDA approval
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
The drug currently approved for chronic kidney disease (CKD) associated with type 2 diabetes, may benefit a much broader group of patients than previously recognized
Day-care model aimed at providing specialized psychological support for women during pregnancy and motherhood
Highlights potential for at-home heart attack risk assessment, offering a new approach to reducing treatment delays
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
Subscribe To Our Newsletter & Stay Updated
